Regeneron Pharmaceuticals, Inc. $REGN Stake Raised by Merit Financial Group LLC

Merit Financial Group LLC significantly increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 115.9% in Q4, now holding 4,013 shares valued at over $3 million. The biopharmaceutical company reported strong Q4 earnings, beating analyst estimates with an EPS of $11.44 and revenue of $3.88 billion, and has a “Moderate Buy” consensus rating from analysts with an average target price of $811.96. Regeneron also raised its quarterly dividend to $0.94 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin